NuCana plc
- NCNA
- NASDAQ
- Biotechnology
- Oncology Drugs
- ProTide Technology
$0.98
Today −1.30%Quote Oct 19, 2026, 08:00 PM UTC
−27.07%over the last month
Max drawdown −27.6%From 1-month high −27.6%3 months −24.2%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
About NuCana
NuCana plc is a clinical-stage biopharmaceutical firm dedicated to pioneering advanced therapies for oncology. Its innovative product pipeline is underpinned by a proprietary ProTide technology platform.
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Employees
11
Market value
$20.34B
Quote Oct 19
Floor
$0.97
0.7% below price
Resistance
$1.03
5.8% above price
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about NCNAPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days free